In:
Biotechnology Journal, Wiley, Vol. 17, No. 7 ( 2022-07)
Abstract:
Alternative cancer models that are close to humans are required to create more valuable preclinical results during oncology studies. Here, a new onco‐pig model via developing a CRISPR‐Cas9‐based Conditional Polycistronic gene expression Cassette (CRI‐CPC) system to control the tumor inducing simian virus 40 large T antigen (SV40LT) and oncogenic HRAS G12V . After conducting somatic cell nuclear transfer (SCNT), transgenic embryos were transplanted into surrogate mothers and five male piglets were born. Umbilical cord analysis confirmed that all piglets were transgenic. Two of them survived and they expressed a detectable green fluorescence. The test was made whether CRI‐CPC models were naturally fertile and whether the CRI‐CPC system was stably transferred to the offspring. By mating with a normal female pig, four offspring piglets were successfully produced. Among them, only three male piglets were transgenic. Finally, their applicability was tested as cancer models after transduction of Cas9 into fibroblasts from each CRI‐CPC pig in vitro, resulting in cell acquisition of cancerous characteristics via the induction of oncogene expression. These results showed that our new CRISPR‐Cas9‐based onco‐pig model was successfully developed.
Type of Medium:
Online Resource
ISSN:
1860-6768
,
1860-7314
DOI:
10.1002/biot.202100434
Language:
English
Publisher:
Wiley
Publication Date:
2022
detail.hit.zdb_id:
2214038-4
